Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance.
Henriksen
E J
EJ
Muscle Metabolism Laboratory, Department of Physiology, University of Arizona College of Medicine, Tucson, AZ 85721-0093, USA.
Jacob
S
S
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000378:metabolism / Q000494:pharmacology*; D001920:Bradykinin / Q000502:physiology; D005947:Glucose / Q000378:metabolism; D051275:Glucose Transporter Type 4; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D009004:Monosaccharide Transport Proteins / Q000378:metabolism; D009124:Muscle Proteins; D018482:Muscle, Skeletal / Q000187:drug effects*; D009569:Nitric Oxide / Q000502:physiology; D011945:Receptors, Angiotensin / Q000502:physiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D051275:Glucose Transporter Type 4; D009004:Monosaccharide Transport Proteins; D009124:Muscle Proteins; D011945:Receptors, Angiotensin; C495692:SLC2A4 protein, human; D009569:Nitric Oxide; D005947:Glucose; D001920:Bradykinin